No sign yet of a specialty London or New York IPO
With Talanx's long-awaited IPO finally away and a generally well-received Direct Line float poised for 11 October, the prospects for insurance IPOs look better than they have for years.
However, to date there is no sign that the private equity backers of specialty players in Bermuda and London are looking more favourably on public offerings as a means of realising the billions tied up in their investment companies.
Talanx, Direct Line and prospective float PICC in China are trailblazers for...
You are currently viewing an incomplete version of this article. If you are a subscriber then please login now. If you are a non-subscriber but would like to be able to view this article, then please select from the purchasing options below.
Purchase
Follow us:
